0916 PDev QTs
BioCentury & Getty Images

Product Development

Sept. 16 Quick Takes: AAT deficiency data lift Arrowhead; plus Metacrine’s IPO, Seer spinout and PDUFA dates for Niemann-Pick, burn therapies 

Sep 17, 2020 | 12:28 AM GMT

Arrowhead gains on AAT deficiency data
Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) gained nearly $1.4

Read the full 437 word article

How to gain access

Continue reading with a
two-week free trial.